Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Cervical cancer statistics
New cases of cervical cancer, 2014, UK
Deaths from cervical cancer, 2014, UK
Survive cervical cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of cervical cancer, UK
- There were around 3,200 new cases of cervical cancer in the UK in 2014, that’s around 9 cases diagnosed every day.
- Cervical cancer is the 20th most common cancer in the UK (2014).
- Cervical cancer accounts for less than 1% of all new cases in the UK (2014).
- In females in the UK, cervical cancer is the 13th most common cancer, with around 3,200 cases diagnosed in 2014.
- More than half (52%) of cervical cancer cases in the UK each year are diagnosed in females aged under 45 (2012-2014).
- Incidence rates for cervical cancer in the UK are highest in people aged 25-29 (2012-2014).
- Since the early 1990s, cervical cancer incidence rates in females have decreased by almost a quarter (23%) in the UK.
- Over the last decade, cervical cancer incidence rates in females have increased by less than a tenth (4%) in the UK.
- Around a quarter of cervical cancer cases are diagnosed late in Northern Ireland (2010-2014).
- Incidence rates for cervical cancer are projected to rise by 43% in the UK between 2014 and 2035, to 17 cases per 100,000 females by 2035.
- 1 in 135 women will be diagnosed with cervical cancer during their lifetime.
- Cervical cancer in England is more common in females living in the most deprived areas.
- Cervical cancer is more common in White females than in Asian females, but similar to Black females, but Asian and Black females are similar to each other.
- An estimated 34,800 women who had previously been diagnosed with cervical cancer were alive in the UK at the end of 2010.
- In Europe, around 58,400 new cases of cervical cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 12th lowest in Europe.
- Worldwide, more than 527,000 women were diagnosed with cervical cancer in 2012, with incidence rates varying across the world.
- There were around 31,800 new cases of in situ cervical carcinoma in the UK in 2014, that’s 87 cases diagnosed every day.
- More than half (54%) of in situ cervical carcinoma cases in the UK each year are diagnosed in females under the age of 30 (2012-2014).
- Incidence rates for in situ cervical carcinoma in the UK are highest in people aged 25-29 (2012-2014).
- Since the early 1990s, in situ cervical carcinoma incidence rates in females have increased by more than a quarter (29%) in the UK.
- Over the last decade, in situ cervical carcinoma incidence rates in females have increased by almost a fifth (18%) in the UK.
- There were around 890 cervical cancer deaths in the UK in 2014, that’s more than 2 deaths every day.
- Cervical cancer accounts for 1% of all cancer deaths in females in the UK (2014).
- In females in the UK, cervical cancer is the 17th most common cause of cancer death, with around 890 deaths in 2014.
- Almost half (47%) of cervical cancer deaths in the UK each year are in females aged 65 and over (2012-2014).
- Mortality rates for cervical cancer in the UK are highest in females aged 85-89 (2012-2014).
- Since the early 1970s, cervical cancer mortality rates in females have decreased by almost three-quarters (72%) in the UK.
- In the past 10 years, cervical cancer mortality rates in females have decreased by almost a quarter (23%) in the UK.
- Mortality rates for cervical cancer are projected to fall by 7% in the UK between 2014 and 2035, to 3 deaths per 100,000 females by 2035.
- Cervical cancer deaths in England are more common in females living in the most deprived areas.
- In Europe, around 24,400 women were estimated to have died from cervical cancer in 2012. The UK mortality rate is ninth lowest in Europe.
- Worldwide, more than 265,000 women are estimated to have died from cervical cancer in 2012, with mortality rates varying across the world.
- Almost two-thirds (63%) of women diagnosed with cervical cancer in England and Wales survive their disease for ten years or more (2010-11).
- Around two-thirds (67%) of women diagnosed with cervical cancer in England and Wales survive their disease for five years or more (2010-11).
- More than 8 in 10 (83%) women diagnosed with cervical cancer in England and Wales survive their disease for one year or more (2010-11).
- Cervical cancer survival in England is highest for women diagnosed aged under 40 years old (2009-2013).
- Around 9 in 10 women in England diagnosed with cervical cancer aged 15-39 survive their disease for five years or more, compared with around a quarter of women diagnosed aged 80 and over (2009-2013).
- Cervical cancer survival is improving and has increased in the last 40 years in the UK.
- In the 1970s, almost half of women diagnosed with cervical cancer survived their disease beyond ten years, now it's almost two-thirds.
- When diagnosed at its earliest stage, around 95% of women with cervical cancer will survive their disease for five years or more, compared with 5 in 100 of women when diagnosed at the latest stage.
- Five-year relative survival for cervical cancer in women is below the European average in England, Wales and Scotland but similar to the European average in Northern Ireland.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 100% of cervical cancer cases each year in the UK are linked to major lifestyle and other risk factors
- High-risk human papillomavirus (HPV) infection is the main potentially avoidable risk factor for cervical cancer, linked to an estimated 100% of cervical cancer cases in the UK.
- Some other factors may relate to cervical cancer risk partly because they are related to HPV. Smoking, human immunodeficiency virus (HIV), and oral contraceptives are associated with cervical cancer.
- ‘Low-risk’ HPV types may relate to increased cervical cancer risk, but evidence is unclear.
- 'GP referral' is the most common route to diagnosing cervical cancer.
- 'Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62-day wait’ is met by all but Wales, Northern Ireland and only partly by Scotland for gynaecological cancers.
- 53% of patients diagnosed with cervical cancer have surgery to remove the tumour as part of their primary cancer treatment.
- 41% of patients diagnosed with cervical cancer have radiotherapy as part of their primary cancer treatment.
- 33% of patients diagnosed with cervical cancer have chemotherapy as part of their primary cancer treatment.
- Almost 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
- 9 in 10 patients are given the name of their Clinical Nurse Specialist.
- Around 7 in 10 (70-73%) of women in Great Britain who are eligible for cervical screening are screened with a definitive usable result for their age.
- Cervical screening coverage in England and Scotland is falling slowly.
- More than 9 in 10 women in Great Britain who have cervical screening receive a negative (normal) result.
- Cervical cancer is found in between 1 and 30 per 1,000 women in England with an abnormal screening result.
The latest statistics available for cervical cancer in the UK are; incidence 2014, mortality 2014 and survival 2010-2011 (all ages combined) and 2009-2013 (by age). Data for in-situ cervical carcinoma are; incidence 2014. Survival data are not available.
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Survival by stage is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past. Survival by stage is available for the former Anglia Cancer Network in the east of England, however. The former Anglia Cancer Network covers around 5% of the population of England and may not be representative of the country as a whole due to differences in underlying demographic factors (such as age, deprivation or ethnicity), as well as variation in local healthcare provision standards and policies.
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Cervical cancer is part of the group 'Gynaecological cancer' for cancer waiting times data. Codes vary per country but broadly include: Vulva, vagina, cervix, uterus, ovary, other female genital organs, placenta and secondary cancers of ovary.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
The latest statistics available for cervical screening in the UK are financial year 2014/15.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.